Data used for this study are third-party data available through the California Cancer Registry, controlled by the California Department of Public Health. The data are available for qualified researchers at the following website upon request (<http://www.ccrcal.org/Data_and_Statistics/Cancer_Data_for_Research.shtml>) Requests for data can be made by individuals and their affiliate institutions through submission of required documents to protect data confidentiality and comply with state law. Policies and procedures for access of confidential data and application materials are available on the California Cancer Registry website (<http://www.ccrcal.org/>). Additional information can be requested from the data disclosure administrator (<research@ccr.ca.gov>). Neighborhood socioeconomic status (nSES) and ethnic enclave variables were based on publicly available data from the American Community Survey results (2007-2011) available at <https://www.census.gov/programs-surveys/acs/>. Census tract level populations were obtained from: <https://factfinder.census.gov/>.

Introduction {#sec005}
============

Lung cancer is the second-most common cancer among both males and females in the U.S. with over 222,500 new cases of lung cancer estimated to be diagnosed in 2017 \[[@pone.0197146.ref001]\]. Lower area-level socioeconomic status (SES) has been associated with a higher incidence of overall lung cancer and non-small-cell lung cancer (NSCLC) among non-Hispanic White and non-Hispanic Black males and females and Asian American/Pacific Islander (AAPI) males \[[@pone.0197146.ref002]--[@pone.0197146.ref005]\]. Disparities in the burden of lung cancer according to area-level SES may be mediated by higher smoking prevalence, lower access to and use of health care services, and/or greater exposure to environmental contaminants such as air pollution, radon, or asbestos among those residing in lower SES neighborhoods \[[@pone.0197146.ref006]--[@pone.0197146.ref010]\]. On the other hand, lower area-level SES has been associated with lower incidence of overall lung cancer and NSCLC among Hispanic males and females \[[@pone.0197146.ref002], [@pone.0197146.ref004], [@pone.0197146.ref005]\]. The reason for this paradoxical association among Hispanics is unknown, but the ethnic composition of neighborhoods, rather than SES, has been suggested to play a key role \[[@pone.0197146.ref011]\]. Finally, while incidence of overall lung cancer and NSCLC according to area-level SES has been examined among AAPI females, no patterns have been reported \[[@pone.0197146.ref002], [@pone.0197146.ref004], [@pone.0197146.ref005]\] and other neighborhood factors such as Asian enclave have not yet been examined among AAPIs.

Lung cancer is divided into two broad histologic cell type categories: small cell lung carcinoma (SCLC) and NSCLC, the latter of which is further divided into adenocarcinoma, squamous cell carcinoma (SCC), and large cell or other specified carcinoma (LC+OSC) subtypes. While prior studies have described incidence of overall lung cancer or NSCLC according to neighborhood factors, none have reported incidence according to types of NSCLC. Histologic cell types, including types of NSCLC, differ in their association with cigarette smoking and nonsmoking-related risk factors \[[@pone.0197146.ref012], [@pone.0197146.ref013]\]. For example, cigarette smoking is the strongest risk factor for every histologic cell-type of lung cancer, but the strength of this association differs by histologic cell-type; it has been reported that SCC and SCLC are more strongly associated with smoking compared to adenocarcinoma and LC+OSC \[[@pone.0197146.ref012]\]. It stands to reason that disentangling the variation in the incidence of histologic cell types according to neighborhood factors may provide insight into possible etiologic differences across racial/ethnic groups and may highlight vulnerable subpopulations at high risk. Therefore, we conducted a large, contemporary population-based study including 75,631 Californians diagnosed from 2008 through 2012 to compare incidence of lung cancer histologic cell-types according to neighborhood SES (nSES) and ethnic enclave status.

Materials and methods {#sec006}
=====================

Study population {#sec007}
----------------

The study population included all incident first primary cases of lung cancer (n = 75,631) diagnosed from January 2008 through December 2012. Cases were identified by the California Cancer Registry (CCR), part of the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program. The study was conducted with IRB oversight from the Cancer Prevention Institute of California. Data on age at cancer diagnosis, sex, race/ethnicity, residential address at diagnosis, and tumor histologic cell type and stage (SEER Summary Stage) were obtained. Histologic cell-types were defined according to Lewis et al. \[[@pone.0197146.ref014]\] for small-cell lung cancer (SCLC), adenocarcinoma, squamous cell carcinoma (SCC), large cell and other specified carcinoma (LC+OSC), and unspecified malignant neoplasms (unspecified). Race/ethnicity was classified as non-Hispanic White, non-Hispanic Black, Hispanic, and non-Hispanic Asian American/Pacific Islander; and are hereafter referred to as White, Black, Hispanic, and AAPI; respectively. Cases with unknown race/ethnicity were excluded (n = 587).

Neighborhood factors {#sec008}
--------------------

A previously developed composite score of neighborhood SES (nSES) was used based on principal component analysis of 2007--2011 American Community Survey (ACS) data on education, housing, employment, occupation, income, and poverty \[[@pone.0197146.ref015], [@pone.0197146.ref016]\]. Hispanic and Asian enclave indices were based on principal components analysis of 2007--2011 ACS variables related to Hispanic and Asian ethnic and immigrant composition and linguistic isolation, respectively \[[@pone.0197146.ref015], [@pone.0197146.ref016]\]. For both nSES and ethnic enclave, each census tract was assigned the appropriate composite score and then categorized in quartiles based on statewide distributions of scores for each factor. Lung cancer cases were assigned quartiles associated with the census tract of the geocoded residential address at diagnosis. A joint nSES+ ethnic enclave variable was created by combining each individual variable into two categories (i.e.; high nSES \[quartiles 1--2\], low nSES \[quartiles 3--4\], high enclave \[quartile 4\], and low enclave \[quartiles 1--3), and categorizing the joint variable into: low nSES/high enclave; low nSES/low enclave; high nSES/high enclave; high nSES/low enclave.

Population data {#sec009}
---------------

The calculation of 5-year incidence rates was based on the availability of the appropriate population denominators at the census tract level from 2010 Census data. The 2010 population counts were multiplied by five to estimate the total population at risk for the 5-year pericensal period of incidence, 2008--2012.

Statistical analysis {#sec010}
--------------------

Incidence rate ratios (IRRs) of lung cancer and 95% confidence intervals (CI) according to quartiles of nSES and Hispanic or Asian ethnic enclave status were estimated based on incidence rates per 100,000 and age-adjusted to the 2010 US Standard population. Stratified analyses were conducted to examine patterns of associations by sex and race/ethnicity. All analyses were conducted using SEER Stat, version 6.3.4 \[[@pone.0197146.ref017]\].

Results {#sec011}
=======

The distribution of neighborhood factors and clinical characteristics among the 75,631 lung cancer cases diagnosed from 2008--2012 are presented in [Table 1](#pone.0197146.t001){ref-type="table"}. Approximately, 67% of Hispanics and 71% of Blacks resided in lower SES neighborhoods (first and second quartiles) in comparison to 41.9% of AAPIs and 42.3% of Whites. Proportionally more Hispanics and AAPIs resided in the highest enclave neighborhoods. Across all racial/ethnic groups combined, adenocarcinoma (47.5%) was the most common histologic cell-type.

10.1371/journal.pone.0197146.t001

###### Distribution of neighborhood factors and clinical characteristics according to race/ethnicity among lung cancer cases, California 2008--2012.
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                                                                       Race/ethnicity                                                                         
  ---------------------------------------------------------- --------- ---------------- --------- --------- --------- --------- --------- --------- --------- ---------
  **nSES**                                                                                                                                                    
  Q4-high                                                    9546      9639             459       528       1373      1177      334       254       7380      7680
                                                             (24.2%)   (26.6%)          (10.4%)   (13.6%)   (27.9%)   (32.4%)   (10.3%)   (9.4%)    (27.5%)   (29.6%)
  Q3                                                         10710     10056            863       878       1410      1008      665       526       7772      7644
                                                             (27.1%)   (27.8%)          (19.6%)   (22.6%)   (28.7%)   (27.7%)   (20.4%)   (19.5%)   (28.9%)   (29.5%)
  Q2                                                         10843     9488             1283      1086      1290      878       910       807       7360      6717
                                                             (27.5%)   (26.2%)          (29.1%)   (27.9%)   (26.2%)   (24.2%)   (27.9%)   (29.8%)   (27.4%)   (25.9%)
  Q1-low                                                     8358      6991             1801      1397      842       571       1349      1117      4366      3906
                                                             (21.2%)   (19.3%)          (40.9%)   (35.9%)   (17.1%)   (15.7%)   (41.4%)   (41.3%)   (16.2%)   (15.1%)
  **Ethnic enclave**[^1^](#t001fn001){ref-type="table-fn"}                                                                                                    
  Q1-low                                                     \~        \~               452       503       202       197       \~        \~        \~        \~
                                                                                        (10.3%)   (12.9%)   (4.1%)    (5.4%)                                  
  Q2                                                         \~        \~               744       805       511       454       \~        \~        \~        \~
                                                                                        (16.9%)   (20.7%)   (10.4%)   (12.5%)                                 
  Q3                                                         \~        \~               1257      1141      965       737       \~        \~        \~        \~
                                                                                        (28.5%)   (29.3%)   (19.6%)   (20.3%)                                 
  Q4- high                                                   \~        \~               1953      1440      3237      2246      \~        \~        \~        \~
                                                                                        (44.3%)   (37.0%)   (65.9%)   (61.8%)                                 
  **Histologic cell-type**                                                                                                                                    
  Adenocarcinoma                                             17126     18803            1897      2084      2584      2610      1386      1317      11259     12792
                                                             (43.4%)   (52.0%)          (43.1%)   (53.6%)   (52.6%)   (71.8%)   (42.5%)   (48.7%)   (41.9%)   (49.3%)
  SCC                                                        9197      5617             982       544       920       290       769       475       6526      4308
                                                             (23.3%)   (15.5%)          (22.3%)   (14.0%)   (18.7%)   (8.0%)    (23.6%)   (17.6%)   (24.3%)   (16.6%)
  SCLC                                                       4243      4102             472       406       412       148       282       296       3077      3252
                                                             (10.8%)   (11.3%)          (10.7%)   (10.4%)   (8.4%)    (4.1%)    (8.7%)    (10.9%)   (11.4%)   (12.5%)
  LC+OSC                                                     2781      2798             374       364       268       175       219       209       1920      2050
                                                             (7.0%)    (7.7%)           (8.5%)    (9.4%)    (5.5%)    (4.8%)    (6.7%)    (7.7%)    (7.1%)    (7.9%)
  Unspecified                                                6109      4854             681       491       730       411       602       407       4096      3545
                                                             (15.5%)   (13.4%)          (15.5%)   (12.6%)   (14.9%)   (11.3%)   (18.5%)   (15.1%)   (15.2%)   (13.7%)
  **Age (years)**                                                                                                                                             
  \< 50                                                      1371      1475             274       308       244       264       131       198       722       705
                                                             (3.5%)    (4.1%)           (6.2%)    (7.9%)    (5.0%)    (7.3%)    (4.0%)    (7.3%)    (2.7%)    (2.7%)
  50--59                                                     5350      4753             610       602       679       601       717       557       3344      2993
                                                             (13.6%)   (13.1%)          (13.8%)   (15.5%)   (13.8%)   (16.5%)   (22.0%)   (20.6%)   (12.4%)   (11.5%)
  60--69                                                     11456     9968             1181      1050      1348      920       1055      842       7872      7156
                                                             (29.0%)   (27.6%)          (26.8%)   (27.0%)   (27.4%)   (25.3%)   (32.4%)   (31.1%)   (29.3%)   (27.6%)
  70--79                                                     13092     11967            1449      1206      1593      1136      968       761       9082      8864
                                                             (33.2%)   (33.1%)          (32.9%)   (31.0%)   (32.4%)   (31.3%)   (29.7%)   (28.1%)   (33.8%)   (34.2%)
  80+                                                        8188      8011             892       723       1051      713       387       346       5858      6229
                                                             (20.8%)   (22.1%)          (20.2%)   (18.6%)   (21.4%)   (19.6%)   (11.9%)   (12.8%)   (21.8%)   (24.0%)
  **Stage**                                                                                                                                                   
  Localized                                                  6602      7634             552       795       706       672       461       455       4883      5712
                                                             (16.7%)   (21.1%)          (12.5%)   (20.4%)   (14.4%)   (18.5%)   (14.1%)   (16.8%)   (18.2%)   (22.0%)
  Regional                                                   8594      7870             886       789       993       701       709       607       6006      5773
                                                             (21.8%)   (21.8%)          (20.1%)   (20.3%)   (20.2%)   (19.3%)   (21.8%)   (22.4%)   (22.3%)   (22.2%)
  Distant                                                    23121     19540            2815      2169      3043      2143      1995      1566      15268     13662
                                                             (58.6%)   (54.0%)          (63.9%)   (55.8%)   (61.9%)   (59.0%)   (61.2%)   (57.9%)   (56.8%)   (52.7%)
  Unstaged                                                   1096      1068             149       127       166       111       92        74        689       756
                                                             (2.8%)    (3.0%)           (3.4%)    (3.3%)    (3.4%)    (3.1%)    (2.8%)    (2.7%)    (2.6%)    (2.9%)

1\. The ethnic enclave variable is defined only for Hispanic and Asian race/ethnicities.

2\. AAPI, Asian American/Pacific Islander; nSES, neighborhood socioeconomic status; IRR, incidence rate ratio; CI, confidence interval; SCC, squamous cell carcinoma; SCLC, small cell lung cancer; LC+OSC, large cell and other cell lung cancer

[Table 2](#pone.0197146.t002){ref-type="table"} and [S1 Fig](#pone.0197146.s001){ref-type="supplementary-material"} present IRRs by nSES for overall lung cancer and histologic cell-types among males, stratified by racial/ethnic group. For overall lung cancer, Black, AAPI, and White male residents of lower SES neighborhoods had higher incidence of lung cancer compared to those in high SES neighborhoods. For adenocarcinoma, White male residents of lower SES neighborhoods had higher incidence (Q1 vs Q4: IRR, 1.42 \[95% CI, 1.34--1.51\]), and a similar pattern was suggested, although non-significant, among Black and AAPI males. In contrast, Hispanic male residents of lower SES neighborhoods, compared to high SES neighborhoods, had lower incidence of adenocarcinoma (Q1 vs. Q4: IRR, 0.86; \[95% CI, 0.74--1.01\]). For all other histologic cell-types (SCLC, SCC, LC+OSC) and unspecified lung cancers, Black, AAPI, and White male residents of lower SES neighborhoods had higher incidence (although IRRs were not significant for Black males with SCLC). For example, a greater than 2.5-fold incidence rate of SCC was observed in White males living in the lowest SES neighborhoods compared to the highest SES neighborhoods (Q1 vs. Q4: IRR, 2.81 \[95% CI, 2.60--3.03\]).

10.1371/journal.pone.0197146.t002

###### Lung cancer incidence rate ratios[^1^](#t002fn001){ref-type="table-fn"} for all lung cancers and histologic cell-types by nSES for males according to race/ethnicity, California 2008--2012.
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                                                           Hispanic   AAPI[^2^](#t002fn002){ref-type="table-fn"}   Black          White                                                                                                                           
  ---------------------------------------------- --------- ---------- -------------------------------------------- -------------- ---------- ------------------ ------------------ ---------- ------------------ ------------------ ---------- ------------------ ------------------
  Overall lung cancer                            Q4-high   459        1.00                                         reference      1373       1.00               reference          334        1.00               reference          7380       1.00               reference
  Q3                                             863       1.01       (0.90, 1.14)                                 1410           **1.19**   **(1.10, 1.28)**   665                **1.16**   **(1.00, 1.34)**   7772               **1.30**   **(1.26, 1.34)**   
                                                 Q2        1283       1.00                                         (0.89, 1.12)   1290       **1.26**           **(1.16, 1.36)**   910        **1.27**           **(1.11, 1.46)**   7360       **1.56**           **(1.51, 1.62)**
                                                 Q1-low    1801       1.02                                         (0.92, 1.14)   842        **1.32**           **(1.20, 1.44)**   1349       **1.50**           **(1.32, 1.71)**   4366       **2.00**           **(1.92, 2.08)**
  Adenocarcinoma                                 Q4-high   224        1.00                                         reference      803        1.00               reference          165        1.00               reference          3584       1.00               reference
                                                 Q3        367        0.88                                         (0.74, 1.05)   747        1.08               (0.98, 1.20)       284        0.95               (0.77, 1.17)       3288       **1.13**           **(1.08, 1.19)**
                                                 Q2        556        0.87                                         (0.74, 1.02)   643        1.09               (0.98, 1.21)       393        1.03               (0.85, 1.26)       2869       **1.25**           **(1.19, 1.31)**
                                                 Q1-low    750        0.86                                         (0.74, 1.01)   391        1.07               (0.94, 1.21)       544        1.18               (0.98, 1.43)       1518       **1.42**           **(1.34, 1.51)**
  SCC[^2^](#t002fn002){ref-type="table-fn"}      Q4-high   95         1.00                                         reference      223        1.00               reference          67         1.00               reference          1508       1.00               reference
                                                 Q3        207        1.20                                         (0.93, 1.57)   252        **1.27**           **(1.05, 1.53)**   160        **1.50**           **(1.11, 2.07)**   1854       **1.53**           **(1.43, 1.64)**
                                                 Q2        289        1.16                                         (0.91, 1.50)   260        **1.53**           **(1.27, 1.85)**   215        **1.64**           **(1.22, 2.24)**   1918       **2.01**           **(1.87, 2.15)**
                                                 Q1-low    391        1.12                                         (0.88, 1.43)   185        **1.69**           **(1.38, 2.07)**   327        **1.93**           **(1.46, 2.60)**   1246       **2.81**           **(2.60, 3.03)**
  SCLC[^2^](#t002fn002){ref-type="table-fn"}     Q4-high   41         1.00                                         reference      88         1.00               reference          31         1.00               reference          706        1.00               reference
                                                 Q3        88         1.12                                         (0.76, 1.70)   123        **1.64**           **(1.23, 2.20)**   57         1.03               (0.63, 1.72)       912        **1.58**           **(1.43, 1.75)**
                                                 Q2        130        1.12                                         (0.77, 1.66)   129        **1.97**           **(1.48, 2.64)**   78         1.19               (0.76, 1.95)       902        **2.03**           **(1.83, 2.24)**
                                                 Q1-low    213        1.35                                         (0.95, 1.97)   72         **1.74**           **(1.25, 2.42)**   116        1.34               (0.87, 2.14)       557        **2.69**           **(2.40, 3.02)**
  LC+OSC[^2^](#t002fn002){ref-type="table-fn"}   Q4-high   34         1.00                                         reference      69         1.00               reference          20         1.00               reference          558        1.00               reference
                                                 Q3        75         1.19                                         (0.78, 1.88)   73         1.31               (0.92, 1.87)       47         1.43               (0.80, 2.64)       546        **1.20**           **(1.07, 1.36)**
                                                 Q2        110        1.07                                         (0.71, 1.65)   77         **1.57**           **(1.11, 2.23)**   64         1.43               (0.83, 2.59)       506        **1.44**           **(1.27, 1.63)**
                                                 Q1-low    155        1.11                                         (0.76, 1.70)   49         **1.66**           **(1.12, 2.46)**   88         **1.77**           **(1.05, 3.16)**   310        **1.89**           **(1.63, 2.18)**
  Unspecified                                    Q4-high   65         1.00                                         reference      189        1.00               reference          51         1.00               reference          1024       1.00               reference
                                                 Q3        126        1.01                                         (0.73, 1.40)   215        **1.26**           **(1.02, 1.55)**   117        1.38               (0.96, 2.03)       1172       **1.42**           **(1.30, 1.55)**
                                                 Q2        198        1.11                                         (0.83, 1.52)   181        1.20               (0.97, 1.48)       160        **1.59**           **(1.12, 2.30)**   1165       **1.78**           **(1.63, 1.94)**
                                                 Q1-low    292        1.16                                         (0.88, 1.57)   145        **1.55**           **(1.23, 1.94)**   274        **2.03**           **(1.46, 2.89)**   735        **2.42**           **(2.19, 2.67)**

1\. Bold type indicates statistical significance

2\. AAPI, Asian American/Pacific Islander; nSES, neighborhood socioeconomic status; IRR, incidence rate ratio; CI, confidence interval; SCC, squamous cell carcinoma; SCLC, small cell lung cancer; LC+OSC, large cell and other cell lung cancer

Among females ([Table 3](#pone.0197146.t003){ref-type="table"} and [S2 Fig](#pone.0197146.s002){ref-type="supplementary-material"}), Blacks and Whites residing in lower SES neighborhoods had higher incidence of overall lung cancer (Blacks Q1 vs. Q4: IRR, 1.43 \[95% CI, 1.25--1.66\] and Whites Q1 vs. Q4: IRR, 1.68 \[95% CI, 1.61--1.75\]) ([Table 3](#pone.0197146.t003){ref-type="table"}). Conversely, Hispanic females residing in lower SES neighborhoods had lower incidence of overall lung cancer (Q1 vs. Q4: IRR, 0.79 \[95% CI, 0.71--0.88\]). For adenocarcinoma and LC+OSC, White females residing in lower SES neighborhoods, compared to high SES neighborhoods, had higher incidence, while Hispanic females residing in lower SES neighborhoods had lower incidence. For SCC and SCLC, Black, AAPI, and White females residing in lower SES neighborhoods, compared to high SES neighborhoods, had higher incidence.

10.1371/journal.pone.0197146.t003

###### Lung cancer incidence rate ratios[^1^](#t003fn001){ref-type="table-fn"} for all lung cancers and histologic cell-types by nSES for females according to race/ethnicity, California 2008--2012.
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                                                           Hispanic   AAPI[^2^](#t003fn002){ref-type="table-fn"}   Black              White                                                                                                             
  ---------------------------------------------- --------- ---------- -------------------------------------------- ------------------ ------- -------------- ------------------ ------- -------------- ------------------ ---------- ------------------ ------------------
  Overall lung cancer                            Q4-high   528        1.00                                         reference          1,177   1.00           reference          254     1.00           reference          7,680      1.00               reference
  Q3                                             878       0.95       (0.85, 1.06)                                 1,008              0.97    (0.89, 1.06)   526                1.09    (0.93, 1.27)   7,644              **1.18**   **(1.14, 1.22)**   
                                                 Q2        1,086      **0.81**                                     **(0.73, 0.91)**   878     1.00           (0.91, 1.09)       807     **1.31**       **(1.13, 1.52)**   6,717      **1.32**           **(1.27, 1.36)**
                                                 Q1-low    1,397      **0.79**                                     **(0.71, 0.88)**   571     1.09           (0.98, 1.21)       1,117   **1.43**       **(1.25, 1.66)**   3,906      **1.68**           **(1.61, 1.75)**
  Adenocarcinoma                                 Q4-high   320        1.00                                         reference          885     1.00           reference          148     1.00           reference          4,312      1.00               Reference
                                                 Q3        487        0.87                                         (0.75, 1.00)       713     0.92           (0.83, 1.01)       268     0.94           (0.76, 1.17)       3,771      1.04               (0.99, 1.08)
                                                 Q2        558        **0.69**                                     **(0.59, 0.79)**   624     0.94           (0.85, 1.05)       410     1.15           (0.94, 1.40)       3,116      **1.09**           **(1.04, 1.14)**
                                                 Q1-low    719        **0.67**                                     **(0.59, 0.77)**   388     1.00           (0.88, 1.13)       491     1.08           (0.89, 1.31)       1,593      **1.23**           **(1.15, 1.30)**
  SCC[^2^](#t003fn002){ref-type="table-fn"}      Q4-high   57         1.00                                         reference          72      1.00           reference          26      1.00           reference          1,010      1.00               Reference
                                                 Q3        105        1.06                                         (0.76, 1.49)       79      1.21           (0.87, 1.71)       85      **1.80**       **(1.13, 2.96)**   1,285      **1.49**           **(1.37, 1.62)**
                                                 Q2        166        1.12                                         (0.83, 1.56)       93      **1.72**       **(1.25, 2.39)**   135     **2.32**       **(1.50, 3.73)**   1,204      **1.77**           **(1.62, 1.93)**
                                                 Q1-low    216        1.11                                         (0.82, 1.52)       46      1.35           (0.91, 2.00)       229     **3.06**       **(2.00, 4.84)**   809        **2.58**           **(2.34, 2.84)**
  SCLC[^2^](#t003fn002){ref-type="table-fn"}     Q4-high   46         1.00                                         reference          37      1.00           reference          21      1.00           reference          730        1.00               Reference
                                                 Q3        83         1.01                                         (0.70, 1.49)       40      1.12           (0.69, 1.82)       48      1.20           (0.70, 2.14)       938        **1.52**           **(1.38, 1.69)**
                                                 Q2        115        1.01                                         (0.71, 1.47)       40      1.32           (0.82, 2.15)       86      1.60           (0.97, 2.75)       959        **1.96**           **(1.77, 2.17)**
                                                 Q1-low    162        1.06                                         (0.75, 1.51)       31      **1.75**       **(1.04, 2.93)**   141     **2.07**       **(1.29, 3.50)**   625        **2.82**           **(2.53, 3.16)**
  LC+OSC[^2^](#t003fn002){ref-type="table-fn"}   Q4-high   52         1.00                                         reference          55      1.00           reference          18      1.00           reference          623        1.00               Reference
                                                 Q3        88         0.97                                         (0.67, 1.40)       50      1.06           (0.71, 1.60)       41      1.11           (0.62, 2.10)       595        **1.15**           **(1.02, 1.29)**
                                                 Q2        108        0.82                                         (0.58, 1.17)       41      1.03           (0.67, 1.59)       59      1.27           (0.73, 2.32)       516        **1.26**           **(1.12, 1.43)**
                                                 Q1-low    116        **0.68**                                     **(0.48, 0.96)**   29      1.21           (0.74, 1.97)       91      1.62           (0.96, 2.91)       316        **1.70**           **(1.47, 1.96)**
  Unspecified                                    Q4-high   53         1.00                                         reference          128     1.00           reference          41      1.00           reference          1,005      1.00               Reference
                                                 Q3        115        1.21                                         (0.86, 1.72)       126     1.09           (0.84, 1.41)       84      1.07           (0.72, 1.62)       1,055      **1.24**           **(1.13, 1.36)**
                                                 Q2        139        1.02                                         (0.74, 1.44)       80      0.81           (0.60, 1.09)       117     1.13           (0.78, 1.68)       922        **1.39**           **(1.26, 1.52)**
                                                 Q1-low    184        1.01                                         (0.74, 1.41)       77      1.28           (0.95, 1.72)       165     1.27           (0.89, 1.86)       563        **1.85**           **(1.67, 2.06)**

1\. Bold type indicates statistical significance

2\. AAPI, Asian American/Pacific Islander; nSES, neighborhood socioeconomic status; IRR, incidence rate ratio; CI, confidence interval; SCC, squamous cell carcinoma; SCLC, small cell lung cancer; LC+OSC, large cell and other cell lung cancer

Tables [4](#pone.0197146.t004){ref-type="table"} and [5](#pone.0197146.t005){ref-type="table"} and [S3](#pone.0197146.s003){ref-type="supplementary-material"} and [S4](#pone.0197146.s004){ref-type="supplementary-material"} Figs present IRRs of overall lung cancer and histologic cell-types by Hispanic and Asian ethnic enclave among Hispanics and AAPI, respectively. Among Hispanics residing in lower Hispanic enclave (more acculturated) neighborhoods compared to higher enclave neighborhoods ([Table 4](#pone.0197146.t004){ref-type="table"} and [S3 Fig](#pone.0197146.s003){ref-type="supplementary-material"}), higher incidence was observed for overall lung cancer and adenocarcinoma among both males and females (adenocarcinoma, Q1 vs. Q4: IRR, 1.24 \[95% CI, 1.05--1.46\] and IRR, 1.64 \[95% CI, 1.42--1.89\], respectively). For SCC and LC+OSC, similar patterns of higher incidence rates for those in lower enclave neighborhoods were observed among Hispanic females. Hispanic females residing in lower enclave neighborhoods, compared to high enclave neighborhoods, also had higher incidence of SCLC (Q1 vs. Q4: IRR, 1.68 \[95% CI, 1.19--2.32\]), but results suggested the opposite pattern of SCLC incidence among Hispanic males residing in lower enclave neighborhoods (Q3 vs. Q4: IRR, 0.72 \[95% CI, 0.56--0.91\]).

10.1371/journal.pone.0197146.t004

###### Lung cancer incidence rate ratios[^1^](#t004fn001){ref-type="table-fn"} for all lung cancers and histologic cell-types by Hispanic ethnic enclave for Hispanic males and females, California 2008--2012.
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                                                           Male   Female                                                          
  ---------------------------------------------- --------- ------ -------------- ------------------ ---------- ------------------ ------------------
  Overall lung cancer                            Q4-high   1953   1.00           reference          1440       1.00               reference
  Q3                                             1257      1.02   (0.95, 1.10)   1141               **1.25**   **(1.15, 1.35)**   
                                                 Q2        744    1.07           (0.97, 1.17)       805        **1.50**           **(1.37, 1.63)**
                                                 Q1-low    452    **1.14**       **(1.02, 1.27)**   503        **1.64**           **(1.48, 1.82)**
  Adenocarcinoma                                 Q4-high   801    1.00           reference          767        1.00               reference
                                                 Q3        569    **1.14**       **(1.01, 1.27)**   600        **1.23**           **(1.10, 1.37)**
                                                 Q2        330    **1.18**       **(1.02, 1.35)**   446        **1.56**           **(1.38, 1.76)**
                                                 Q1-low    197    **1.24**       **(1.05, 1.46)**   271        **1.64**           **(1.42, 1.89)**
  SCC[^2^](#t004fn002){ref-type="table-fn"}      Q4-high   430    1.00           reference          197        1.00               reference
                                                 Q3        276    1.02           (0.87, 1.19)       174        **1.42**           **(1.15, 1.76)**
                                                 Q2        165    1.03           (0.85, 1.24)       110        **1.49**           **(1.17, 1.90)**
                                                 Q1-low    111    1.20           (0.96, 1.49)       63         **1.58**           **(1.17, 2.11)**
  SCLC[^2^](#t004fn002){ref-type="table-fn"}     Q4-high   237    1.00           reference          149        1.00               reference
                                                 Q3        114    **0.72**       **(0.56, 0.91)**   116        1.17               (0.90, 1.50)
                                                 Q2        83     0.96           (0.73, 1.25)       89         **1.56**           **(1.18, 2.05)**
                                                 Q1-low    38     0.73           (0.49, 1.04)       52         **1.68**           **(1.19, 2.32)**
  LC+OSC[^2^](#t004fn002){ref-type="table-fn"}   Q4-high   165    1.00           reference          128        1.00               reference
                                                 Q3        117    1.26           (0.97, 1.63)       117        **1.48**           **(1.13, 1.93)**
                                                 Q2        51     0.89           (0.62, 1.24)       68         **1.43**           **(1.04, 1.95)**
                                                 Q1-low    41     1.42           (0.97, 2.03)       51         **1.93**           **(1.35, 2.70)**
  Unspecified                                    Q4-high   320    1.00           reference          199        1.00               reference
                                                 Q3        181    0.88           (0.72, 1.07)       134        1.06               (0.84, 1.34)
                                                 Q2        115    1.01           (0.8, 1.27)        92         1.23               (0.95, 1.59)
                                                 Q1-low    65     0.96           (0.71, 1.27)       66         **1.53**           **(1.13, 2.04)**

1\. Bold type indicates statistical significance

2\. IRR, incidence rate ratio; CI, confidence interval; SCC, squamous cell carcinoma; SCLC, small cell lung cancer; LC+OSC, large cell and other cell lung cancer

10.1371/journal.pone.0197146.t005

###### Lung cancer incidence rate ratios[^1^](#t005fn001){ref-type="table-fn"} for all lung cancers and histologic cell-types[^2^](#t005fn002){ref-type="table-fn"} by Asian ethnic enclave for AAPI[^3^](#t005fn003){ref-type="table-fn"} males and females, California 2008--2012.
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                                                         Male   Female                                              
  -------------------------------------------- --------- ------ -------------- -------------- ------ -------------- ------------------
  Overall lung cancer                          Q4-high   3237   1.00           reference      2246   1.00           reference
  Q3                                           965       0.96   (0.89, 1.03)   737            0.99   (0.91, 1.08)   
                                               Q2        511    0.93           (0.84, 1.02)   454    1.08           (0.97, 1.20)
                                               Q1-low    202    0.93           (0.80, 1.08)   197    1.15           (0.99, 1.33)
  Adenocarcinoma                               Q4-high   1714   1.00           reference      1667   1.00           reference
                                               Q3        505    0.93           (0.84, 1.04)   520    0.93           (0.84, 1.02)
                                               Q2        263    0.91           (0.79, 1.04)   298    0.96           (0.84, 1.09)
                                               Q1-low    102    0.89           (0.72, 1.09)   125    0.98           (0.81, 1.18)
  SCC[^3^](#t005fn003){ref-type="table-fn"}    Q4-high   591    1.00           reference      145    1.00           reference
                                               Q3        185    1.03           (0.87, 1.22)   73     **1.59**       **(1.18, 2.13)**
                                               Q2        99     1.01           (0.80, 1.25)   44     **1.68**       **(1.16, 2.37)**
                                               Q1-low    45     1.13           (0.80, 1.54)   28     **2.64**       **(1.69, 4.01)**
  SCLC[^3^](#t005fn003){ref-type="table-fn"}   Q4-high   278    1.00           reference      79     1.00           reference
                                               Q3        72     0.83           (0.62, 1.08)   31     1.21           (0.76, 1.86)
                                               Q2        42     0.86           (0.60, 1.20)   20     1.32           (0.76, 2.21)
                                               Q1-low    20     0.99           (0.58, 1.58)   18     **2.86**       **(1.59, 4.91)**
  Unspecified                                  Q4-high   467    1.00           reference      257    1.00           reference
                                               Q3        154    1.04           (0.86, 1.26)   70     0.84           (0.64, 1.11)
                                               Q2        82     1.00           (0.77, 1.27)   68     **1.36**       **(1.02, 1.79)**
                                               Q1-low    27     0.92           (0.59, 1.36)   16     0.80           (0.45, 1.35)

1\. Bold type indicates statistical significance

2\. Results not provided for LC+OSC due to low numbers

3\. AAPI, Asian American/Pacific Islander; IRR, incidence rate ratio; CI, confidence interval; SCC, squamous cell carcinoma; SCLC, small cell lung cancer; LC+OSC, large cell and other cell lung cancer

Among AAPI males ([Table 5](#pone.0197146.t005){ref-type="table"} and [S4 Fig](#pone.0197146.s004){ref-type="supplementary-material"}), there were no differences in incidence of overall lung cancer or specific histologic cell-types according to Asian ethnic enclave. There were also no differences in incidence of overall lung cancer or adenocarcinoma according to Asian ethnic enclave among AAPI females. However, AAPI females residing in lower relative to higher enclave neighborhoods had substantially higher incidence of SCC and SCLC (Q1 vs. Q4: IRR, 2.64 \[95%CI, 1.69--4.01\] and IRR, 2.86 \[95% CI, 1.59--4.91\], respectively).

We also examined incidence of overall lung cancer and adenocarcinoma (the most common histologic cell-type) jointly by nSES and ethnic enclave ([Table 6](#pone.0197146.t006){ref-type="table"} and [S5 Fig](#pone.0197146.s005){ref-type="supplementary-material"}). For overall lung cancer, Hispanic males residing in low SES, low enclave neighborhoods had higher incidence compared to those in low SES, high enclave neighborhoods. On the other hand, Hispanic females residing in low enclave neighborhoods regardless of SES had higher overall lung cancer incidence than those residing in low SES, high enclave neighborhoods. For adenocarcinoma, Hispanic males and females, residing in both low nSES and high nSES neighborhoods that were low enclave had higher incidence of adenocarcinoma compared to those residing in low nSES, high enclave neighborhoods; males (IRR, 1.17 \[95% CI, 1.04--1.32\] and IRR, 1.15 \[95% CI, 1.02--1.29\], respectively) and females (IRR, 1.29 \[95% CI, 1.15--1.44\] and IRR, 1.51 \[95% CI, 1.36--1.67\], respectively). For overall lung cancer, only AAPI males residing in high SES, low enclave neighborhoods had lower incidence than those residing in low SES, high enclave neighborhoods (IRR, 0.81; 95% CI, 0.76--0.87). However, AAPI males residing in both low SES and high SES, low enclave neighborhoods had lower adenocarcinoma incidence. There were no differences in incidence of overall lung cancer or adenocarcinoma by the joint nSES/ethnic enclave measure among AAPI females. We were unable to examine incidence of other histologic cell types jointly by nSES and enclave status due to low numbers of cases.

10.1371/journal.pone.0197146.t006

###### Lung cancer incidence rate ratios[^1^](#t006fn001){ref-type="table-fn"} for all lung cancers and lung adenocarcinomas by joint nSES, ethnic enclave for Hispanic and AAPI males and females, California 2008--2012.
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  ----------------------- ---------------------------------------------------------------- ----------- ----------------------------------------------- -------------------------------------------------------- ----------- ------------------ ------------------
  **Hispanic**                                                                                                                                                                                                                                 
                                                                                           **Male**    **Female**                                                                                                                              
                          **nSES, ethnic enclave**[^2^](#t006fn002){ref-type="table-fn"}   **Cases**   **IRR**[^3^](#t006fn003){ref-type="table-fn"}   **(95% CI**[^3^](#t006fn003){ref-type="table-fn"}**)**   **Cases**   **IRR**            **(95% CI)**
  Overall lung cancer     Low nSES, High enclave                                           1896        1.00                                                                                                     1390        1.00               
  Low nSES, Low enclave   1188                                                             **1.09**    **(1.01, 1.18)**                                1093                                                     **1.41**    **(1.29, 1.53)**   
                          High nSES, High enclave                                          57          1.03                                            (0.77, 1.35)                                             50          1.14               (0.84, 1.51)
                          High nSES, Low enclave                                           1265        1.03                                            (0.95, 1.11)                                             1356        **1.39**           **(1.29, 1.51)**
  Adenocarcinoma          Low nSES, High enclave                                           784         1.00                                            reference                                                740         1.00               reference
                          Low nSES, Low enclave                                            522         **1.17**                                        **(1.04, 1.32)**                                         537         **1.29**           **(1.15, 1.44)**
                          High nSES, High enclave                                          17          0.79                                            (0.45, 1.27)                                             27          1.14               (0.74, 1.67)
                          High nSES, Low enclave                                           574         **1.15**                                        **(1.02, 1.29)**                                         780         **1.51**           **(1.36, 1.67)**
  **AAPI**^**3**^                                                                                                                                                                                                                              
                                                                                           **Male**    **Female**                                                                                                                              
                          **nSES, ethnic enclave**                                         **Cases**   **IRR**                                         **(95% CI)**                                             **Cases**   **IRR**            **(95% CI)**
  Overall lung cancer     Low nSES, High enclave                                           1153        1.00                                                                                                     720         1.00               
  Low nSES, Low enclave   979                                                              0.93        (0.86, 1.02)                                    729                                                      1.05        (0.94, 1.16)       
                          High nSES, High enclave                                          122         1.10                                            (0.91, 1.34)                                             85          1.16               (0.91, 1.46)
                          High nSES, Low enclave                                           2661        **0.81**                                        **(0.76, 0.87)**                                         2100        0.98               (0.89, 1.06)
  Adenocarcinoma          Low nSES, High enclave                                           575         1.00                                                                                                     524         1.00               
                          Low nSES, Low enclave                                            459         **0.88**                                        **(0.77, 0.99)**                                         488         0.96               (0.84, 1.09)
                          High nSES, High enclave                                          61          1.10                                            (0.82, 1.44)                                             60          1.10               (0.83, 1.45)
                          High nSES, Low enclave                                           1489        **0.90**                                        **(0.82, 0.99)**                                         1538        0.97               (0.88, 1.08)
  ----------------------- ---------------------------------------------------------------- ----------- ----------------------------------------------- -------------------------------------------------------- ----------- ------------------ ------------------

1\. Bold type indicates statistical significance.

2\. Low nSES, quartiles 1--2; High SES, quartiles 3--4; High enclave, quartile 4; Low enclave, quartiles 1--3.

3\. AAPI, Asian American/Pacific Islander; IRR, incidence rate ratio; CI, confidence interval.

Discussion {#sec012}
==========

In this population-based study with over 75,000 lung cancer cases, we observed higher incidence of lung cancer among Black and White males and females and AAPI males residing in lower SES neighborhoods. In contrast, incidence did not differ by nSES among AAPI females and Hispanic males, while an inverse association was observed among Hispanic females such that lung cancer incidence was actually lower in lower SES neighborhoods. However, examining histologic cell-type-specific lung cancer incidence according to nSES indicated somewhat varying patterns, especially among Hispanics and AAPIs. Among Hispanics and AAPIs, we also observed varying patterns of lung cancer incidence according to ethnic enclave that were specific to groups defined by sex, race/ethnicity, and histologic cell type. Examining incidence patterns jointly by nSES and ethnic enclave among Hispanics and AAPIs suggested that nSES-related gradients may, in some cases, be driven more by ethnic enclave status rather than by SES.

Previous studies have reported higher incidence of overall lung cancer among those of lower area-level SES \[[@pone.0197146.ref002]--[@pone.0197146.ref005]\] for most groups defined by sex and race/ethnicity, similar to our report. Higher incidence of overall lung cancer among Black and White males and females residing in lower SES neighborhoods likely reflects higher levels of smoking among Black and White residents of low SES neighborhoods \[[@pone.0197146.ref007], [@pone.0197146.ref018], [@pone.0197146.ref019]\]. Similar to previous studies, we also report lower incidence of overall lung cancer among Hispanic females residing in lower SES neighborhoods and null associations among AAPI females \[[@pone.0197146.ref002], [@pone.0197146.ref004], [@pone.0197146.ref005]\]. However, contrary to previous reports, we do not observe patterns of overall lung cancer incidence by nSES among Hispanic males \[[@pone.0197146.ref002], [@pone.0197146.ref004], [@pone.0197146.ref005]\]. This result from our contemporary population (2008--2012) may reflect changing associations over time as Wong et al., in a study of lung cancer cases from 1988--2002, reported a positive linear trend between nSES and NSCLC incidence among Hispanic males that was driven by older age groups \[[@pone.0197146.ref004]\].

The pattern of higher lung cancer incidence for residents of lower SES neighborhoods generally holds for most histologic cell-types among AAPI males and Black and White males and females. However, this pattern was least consistent for adenocarcinoma across races/ethnicities and the magnitude of effect was generally smaller. The association between smoking and adenocarcinoma is weaker compared to other histologic cell-types \[[@pone.0197146.ref012], [@pone.0197146.ref020]\], thus our results likely reflect other environmental exposures and genetic and molecular factors (that presumably are not as strongly associated with nSES as smoking) as the driving factors of adenocarcinoma development \[[@pone.0197146.ref012], [@pone.0197146.ref020]\]. In fact, with increasing understanding of the high rates of epidermal growth factor receptor (*EGFR*) mutated lung cancer in non-smoking Asian and Hispanic women, it is clear that the etiology of this subtype of lung cancer is quite different than the more common smoking-associated subtypes \[[@pone.0197146.ref021]--[@pone.0197146.ref023]\].

Previous studies have suggested that, compared to nSES, acculturation factors may be stronger predictors of lung cancer incidence among Hispanics \[[@pone.0197146.ref004], [@pone.0197146.ref011]\]. In a SEER study of lung cancers diagnosed among Hispanics (1988--1992), Eschbach et al. reported that Hispanic males and females residing in census tracts with less than 20% Hispanic populations had higher incidence of overall lung cancer \[[@pone.0197146.ref011]\]. Our results confirm this with a contemporary Hispanic population, using a multi-component Hispanic ethnic enclave measure \[[@pone.0197146.ref015], [@pone.0197146.ref024]\], and further show that the influence of Hispanic ethnic enclave on lung cancer incidence differs by sex and lung cancer histologic cell-type: lower Hispanic enclave was associated with greater incidence only for Hispanic males with adenocarcinoma, but across all histologic cell-types for Hispanic females. We found that low ethnic enclave drives patterns in lung adenocarcinoma incidence among Hispanic male and female residents, an effect that seemed particularly strong for Hispanic females. However, for overall lung cancer incidence, the observation that only Hispanic males residing in neighborhoods of both low nSES and low enclave had higher incidence of overall lung cancer indicates the importance of both nSES and ethnic enclave.

There is little information in the literature regarding associations between neighborhood acculturation and smoking prevalence among Hispanic adults. A study of Mexican adults reported null associations between neighborhood acculturation factors and smoking rates, but the multi-level model included a potential mediator, individual acculturation, which has been associated with increased rates of smoking among Hispanics, especially Hispanic females \[[@pone.0197146.ref025]--[@pone.0197146.ref027]\]. Furthermore, ethnic enclaves may influence smoking rates (for better or worse) via pathways both dependent and independent of individual acculturation. Additional potential mediators of enclave on smoking prevalence include the reinforcement of cultural norms \[[@pone.0197146.ref024], [@pone.0197146.ref028]\], discrimination and chronic stress \[[@pone.0197146.ref024]\], and targeted tobacco advertising \[[@pone.0197146.ref029]\]. In addition, the effects of ethnic enclaves on smoking rates among Hispanics likely differ by the dominant national origin within the neighborhood; \[[@pone.0197146.ref026], [@pone.0197146.ref030]\]. For example, Puerto Rican-Americans and Cuban-Americans were more likely to be heavy smokers than Mexican-Americans \[[@pone.0197146.ref030]\]. In California, the Hispanic population is predominantly of Mexican origin \[[@pone.0197146.ref031]\].

To our knowledge, no prior study has considered Asian ethnic enclave and lung cancer incidence among AAPIs. Examining incidence jointly by nSES and ethnic enclave among AAPI males indicates significantly lower incidence of adenocarcinoma for residents of low enclave neighborhoods, regardless of nSES, which suggests that high ethnic enclave drives adenocarcinoma incidence in this group. Among AAPI females, neighborhood SES and Asian enclave status may be less relevant to the etiology of adenocarcinoma and LC+OSC. Our power was limited to evaluate joint associations for other sub-types, where independent associations for nSES and enclave were much stronger, as was the case with SCC and SCLC histologic cell-types. To our knowledge, only one study by Kandula et al. addressed associations between neighborhood factors and smoking prevalence among Asians \[[@pone.0197146.ref032]\] and reported that, among Asian females, residing in a neighborhood with a lower percent of Asians was associated with a higher smoking prevalence. Therefore, our findings for the SCC and SCLC histologic cell-types, the two cell-types most strongly associated with smoking, may be due to higher smoking among AAPI females living in lower enclave neighborhoods \[[@pone.0197146.ref032]\].

Furthermore, any influence of ethnic enclave on smoking or other lung cancer risk factors among AAPIs is likely influenced by the dominant neighborhood culture, as ever-smoking prevalence among AAPI males differs greatly by national origin, ranging from 15% among Vietnamese males to 59% among Native Hawaiian/Pacific Islander males \[[@pone.0197146.ref033]\]. In addition, ever-smoking prevalence varies widely according to national origin among Asian females, ranging from 0.3% in Vietnamese to 40% in Japanese females \[[@pone.0197146.ref033]\]. Thus, future studies should consider smoking status in addition to nSES, ethnic enclave, and histologic sub-type among AAPIs, as well as associations between neighborhood factors and lung cancer incidence across specific AAPI subgroups.

There are several strengths to our study. Our study included a large population-based sample of diverse lung cancer cases with sufficient numbers to address subtypes separately and utilized composite indices for measuring nSES and neighborhood acculturation \[[@pone.0197146.ref015]\]. As a result, we were able to uncover undocumented associations between neighborhood factors and lung cancer incidence. However, our study does have some limitations. We were unable to disaggregate AAPIs and Hispanics into specific populations defined by national origin or immigration status, due to lack of appropriate population denominator data. In addition, we were unable to evaluate clinical factors (such as tumor associated mutations), individual-level factors such as smoking history, passive smoking, family history of lung cancer, use of medical services, environmental exposures, or individual measures of SES or acculturation due to lack of availability of this data. Estimates of neighborhood-level smoking prevalences are not available, but would provide a clearer picture of neighborhood factors that correlate with aggregate smoking behavior. Finally, individuals' residential history would improve the study of neighborhood factors associated with lung cancer risk, as it would provide a more accurate portrait of the lung cancer risk period.

Conclusion {#sec013}
==========

Our study illustrates varying patterns of incidence of lung cancer histologic cell types according to neighborhood SES and ethnic enclave by sex and race/ethnicity. It is important for continuing research on lung cancer etiology to consider, in addition to individual-level exposures (e.g.; smoking status, individual-level SES), the clear contextual-level effects of nSES and, for Hispanics and AAPIs, the joint effects of nSES and ethnic enclave.
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###### Lung cancer incidence rate ratios (IRRs) and 95% confidence intervals (95% CIs) according to neighborhood SES (nSES) quartile for lung cancer histologic cell-types among [males]{.ul} diagnosed in California 2008--2012.

IRRs and 95% CIs for (A) overall lung cancer, (B) adenocarcinoma, (C) squamous cell carcinoma (SCC), (D) small-cell lung carcinoma (SCLC), (E) large-cell and other specified carcinoma (LC+OSC), and (F) unspecified lung cancers among non-Hispanic White (White, orange), non-Hispanic Black (Black, green), Asian American and Pacific Islander (AAPI, red), and Hispanic (blue) males. Markers represent IRRs and horizontal solid lines represent 95% CIs. The highest nSES quartile (Q4) serves as the reference category (IRR, 1.0; represented by the vertical dotted line).
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Click here for additional data file.

###### Lung cancer incidence rate ratios (IRRs) and 95% confidence intervals (95% CIs) according to neighborhood SES (nSES) quartile for lung cancer histologic cell-types among [females]{.ul} diagnosed in California 2008--2012.

IRRs and 95% CIs for (A) overall lung cancer, (B) adenocarcinoma, (C) squamous cell carcinoma (SCC), (D) small-cell lung carcinoma (SCLC), (E) large-cell and other specified carcinoma (LC+OSC), and (F) unspecified lung cancers among non-Hispanic White (White, orange), non-Hispanic Black (Black, green), Asian American and Pacific Islander (AAPI, red), and Hispanic (blue) females. Markers represent IRRs and horizontal solid lines represent 95% CIs. The highest nSES quartile (Q4) serves as the reference category (IRR, 1.0; represented by the vertical dotted line).
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Click here for additional data file.

###### Lung cancer incidence rate ratios (IRRs) and 95% confidence intervals (95% CIs) according to quartile of neighborhood [Hispanic]{.ul} ethnic enclave for lung cancer histologic cell-types among Hispanic males and females diagnosed in California 2008--2012.

IRRs and 95% CIs for overall lung cancer (black), adenocarcinoma (blue), squamous cell carcinoma (SCC, red), small-cell lung carcinoma (SCLC, green), large-cell and other specified cell carcinoma (LC+OSC, orange), and unspecified lung cancers (purple) among Hispanic (A) males and (B) females. Markers represent IRRs and horizontal solid lines represent 95% CIs. The highest quartile of neighborhood Hispanic ethnic enclave (Q4) serves as the reference category (IRR, 1.0, represented by the vertical dotted line).

(DOCX)

###### 

Click here for additional data file.

###### Lung cancer incidence rate ratios (IRRs) and 95% confidence intervals (95% CIs) according to quartile of neighborhood [Asian]{.ul} ethnic enclave for lung cancer histologic cell types among Asian American and Pacific Islander (AAPI) males and females diagnosed in California 2008--2012.

IRRs and 95% CIs for overall lung cancer (black), adenocarcinoma (blue), squamous cell carcinoma (SCC, red), small-cell lung carcinoma (SCLC, green), large-cell and other specified cell carcinoma (LC+OSC, orange), and unspecified lung cancers (purple) among AAPI (A) males and (B) females. Markers represent IRRs and horizontal solid lines represent 95% CIs. The highest quartile of neighborhood Asian ethnic enclave (Q4) serves as the reference category (IRR, 1.0, represented by the vertical dotted line).
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Click here for additional data file.

###### Lung cancer incidence rate ratios (IRRs) and 95% confidence intervals (95% CIs) according to joint neighborhood socioeconomic status (nSES) and ethnic enclave among Hispanic and Asian American Pacific Islander (AAPI) males and females diagnosed in California 2008--2012.

IRRs and 95% CIs for nSES/Hispanic ethnic enclave for all lung cancer (blue) and adenocarcinoma (red) among (A) Hispanic males and (B) Hispanic females and according to joint nSES/Asian ethnic enclave among (C) AAPI males and (D) AAPI females. Markers represent IRRs and horizontal solid lines represent 95% CIs. Low nSES/High enclave serves as the reference category (IRR, 1.0).
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###### 

Click here for additional data file.
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